S100A1 and S100B Expression Patterns Identify Differentiation Status of Human Articular Chondrocytes. Issue 8 (August 2014)

• Record Type: Journal Article
• Authors: Diaz‐Romero, Jose; Quintin, Aurelie; Schoenholzer, Eric; Pauli, Chantal; Despont, Alain; Zumstein, Matthias A.; Kohl, Sandro; Nesic, Dobrila
• Is Part Of: Journal of cellular physiology. Volume 229:Issue 8(2014:Aug.)
• Page Start: 1106
• Page End: 1117
• Publication Date: 2014-08
• Subjects: Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.24547
• Languages: English
• ISSNs: 0021-9541

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="jcp24547-sec-0001" sec-type="section"> <p>Many studies in the field of cell‐based cartilage repair have focused on identifying markers associated with the differentiation status of human articular chondrocytes (HAC) that could predict their chondrogenic potency. A previous study from our group showed a correlation between the expression of S100 protein in HAC and their chondrogenic potential. The aims of the current study were to clarify which S100 proteins are associated with HAC differentiation status and to provide an S100‐based assay for measuring HAC chondrogenic potential. The expression patterns of S100A1 and S100B were investigated in cartilage and in HAC cultured under conditions promoting dedifferentiation (monolayer culture) or redifferentiation (pellet culture or BMP4 treatment in monolayer culture), using characterized antibodies specifically recognizing S100A1 and S100B, by immunohistochemistry, immunocytochemistry, Western blot, and gene expression analysis. S100A1 and S100B were expressed homogeneously in all cartilage zones, and decreased during dedifferentiation. S100A1, but not S100B, was re‐expressed in pellets and co‐localized with collagen II. Gene expression analysis revealed concomitant modulation of S100A1, S100B, collagen type II, and aggrecan: down‐regulation during monolayer culture and up‐regulation upon BMP4 treatment. These results strongly support an association of S100A1, and to a lesser extent S100B, with the HAC differentiated phenotype. To facilitate their potential application, we established an S100A1/B‐based flow cytometry assay for accurate assessment of HAC differentiation status. We propose S100A1 and S100B expression as a marker to develop potency assays for cartilage regeneration cell therapies, and as a redifferentiation readout in monolayer cultures aiming to investigate stimuli for chondrogenic induction. J. Cell. Physiol. 229: 1106–1117, 2014. © 2014 Wiley Periodicals, Inc.</p> </sec> </abstract>